{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:06:45Z","timestamp":1761844005556},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00428-010-0993-6","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T16:01:43Z","timestamp":1286985703000},"page":"715-725","source":"Crossref","is-referenced-by-count":31,"title":["Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours?"],"prefix":"10.1007","volume":"457","author":[{"given":"Iola F.","family":"Duarte","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia M.","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio S.","family":"Barros","sequence":"additional","affiliation":[]},{"given":"Ana M.","family":"Gil","sequence":"additional","affiliation":[]},{"given":"Brian J.","family":"Goodfellow","sequence":"additional","affiliation":[]},{"given":"Isabel M.","family":"Carreira","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Bernardo","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Vitor","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Lina","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"key":"993_CR1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrc1390","volume":"4","author":"JL Griffin","year":"2004","unstructured":"Griffin JL, Shockor JP (2004) Metabolic profiles of cancer cells. Nat Rev Cancer 4:551\u2013561","journal-title":"Nat Rev Cancer"},{"key":"993_CR2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabonomics in oncology: a review. Clin Cancer Res 15:431\u2013440","journal-title":"Clin Cancer Res"},{"key":"993_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/bmm.09.15","volume":"3","author":"AL Merz","year":"2009","unstructured":"Merz AL, Serkova NJ (2009) Use of nuclear magnetic resonance-based metabonomics in detecting drug resistance in cancer. Biomark Med 3:289\u2013306","journal-title":"Biomark Med"},{"key":"993_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pnmrs.2008.10.001","volume":"54","author":"B Sitter","year":"2009","unstructured":"Sitter B, Bathen TF, Tessem M-B, Gribbestad IS (2009) High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer. Prog Nucl Magn Reson Spectrosc 54:239\u2013254","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"993_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mrm.1910290403","volume":"29","author":"H Hanaoka","year":"1993","unstructured":"Hanaoka H, Yoshioka Y, Ito I, Niitu K, Yasuda N (1993) In vitro characterization of lung cancers by the use of 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn Reson Med 29:436\u2013440","journal-title":"Magn Reson Med"},{"key":"993_CR6","first-page":"1334","volume":"45","author":"JF Guo","year":"2004","unstructured":"Guo JF, Higashi K, Yokota H, Nagao Y, Ueda Y, Kodama Y, Oguchi M, Taki S, Tonami H, Yamamoto I (2004) In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma. J Nucl Med 45:1334\u20131339","journal-title":"J Nucl Med"},{"key":"993_CR7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jmri.20902","volume":"25","author":"H Yokota","year":"2007","unstructured":"Yokota H, Guo J, Matoba M, Higashi K, Tonami H, Nagao Y (2007) Lactate, choline and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer. J Magn Reson Imaging 25:992\u2013999","journal-title":"J Magn Reson Imaging"},{"key":"993_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yexmp.2009.04.004","volume":"87","author":"TW-M Fan","year":"2009","unstructured":"Fan TW-M, Lane AN, Higashi RM, Bousamra M, Kloecker G, Miller DM (2009) Metabolic profiling identifies lung tumour responsiveness to erlotinib. Exp Mol Pathol 87:83\u201386","journal-title":"Exp Mol Pathol"},{"key":"993_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-8-41","volume":"8","author":"TW-M Fan","year":"2009","unstructured":"Fan TW-M, Lane AN, Higashi RM, Farag MA, Gao H, Bousamra M, Miller DM (2009) Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Mol Cancer 8:41","journal-title":"Mol Cancer"},{"key":"993_CR10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mrm.10614","volume":"50","author":"MG Swanson","year":"2003","unstructured":"Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J (2003) Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI\/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 50:944\u2013954","journal-title":"Magn Reson Med"},{"key":"993_CR11","first-page":"859","volume":"18","author":"V Tugnoli","year":"2006","unstructured":"Tugnoli V, Schenetti L, Mucci A, Parenti F, Cagnoli R, Righi V, Trinchero A, Nocetti L, Toraci C, Mavilla L, Trentini G, Zunarelli E, Tosi MR (2006) Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra. Int J Mol Med 18:859\u2013869","journal-title":"Int J Mol Med"},{"key":"993_CR12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jmri.20668","volume":"24","author":"C Mountford","year":"2006","unstructured":"Mountford C, Lean C, Malycha P, Russell P (2006) Proton spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging 24:459\u2013477","journal-title":"J Magn Reson Imaging"},{"key":"993_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/nbm.1310","volume":"22","author":"MA Thomas","year":"2009","unstructured":"Thomas MA, Lipnick S, Velan SS, Liu X, Banakar S, Binesh N, Ramadan S, Ambrosio A, Raylman RR, Sayre J, DeBruhl N, Bassett L (2009) Investigation of breast cancer using two-dimensional MRS. NMR Biomed 22:77\u201391","journal-title":"NMR Biomed"},{"key":"993_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nbm.1306","volume":"22","author":"M Wilson","year":"2009","unstructured":"Wilson M, Davies NP, Grundyd RG, Peet AC (2009) A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours. NMR Biomed 22:213\u2013219","journal-title":"NMR Biomed"},{"key":"993_CR15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/nbm.992","volume":"19","author":"B Sitter","year":"2006","unstructured":"Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 19:30\u201340","journal-title":"NMR Biomed"},{"key":"993_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-006-9400-z","volume":"104","author":"TF Bathen","year":"2007","unstructured":"Bathen TF, Jensen LR, Sitter B, Fjosne HE, Halgunset J, Axelson DE, Gribbestad IS, Lundgren S (2007) MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 104:181\u2013189","journal-title":"Breast Cancer Res Treat"},{"key":"993_CR17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/mrm.21486","volume":"59","author":"G Erb","year":"2008","unstructured":"Erb G, Elbayed K, Piotto M, Raya J, Neuville A, Mohr M, Maitrot D, Kehrli P, Namer IJ (2008) Toward improved grading of malignancy in oligodendrogliomas using metabolomics. Magn Reson Med 59:959\u2013965","journal-title":"Magn Reson Med"},{"key":"993_CR18","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1021\/pr800110a","volume":"7","author":"D Monleon","year":"2008","unstructured":"Monleon D, Morales JM, Gonzalez-Darder J, Talamantes F, Cortes O, Gil-Benso R, Lopez-Gines C, Cerda-Nicolas M, Celda B (2008) Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. J Proteome Res 7:2882\u20132888","journal-title":"J Proteome Res"},{"key":"993_CR19","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1158\/0008-5472.CAN-04-4106","volume":"65","author":"LL Cheng","year":"2005","unstructured":"Cheng LL, Burns MA, Taylor JL, He W, Halpern EF, McDougal WS, Wu C-L (2005) Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 65:3030\u20133034","journal-title":"Cancer Res"},{"key":"993_CR20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mrm.21694","volume":"60","author":"M-B Tessem","year":"2008","unstructured":"Tessem M-B, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J (2008) Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med 60:510\u2013516","journal-title":"Magn Reson Med"},{"key":"993_CR21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10334-008-0156-9","volume":"21","author":"JJA Asten van","year":"2008","unstructured":"van Asten JJA, Cuijpers V, Hulsbergen-van de Kaa C, Soede-Huijbregts C, Witjes JA, Verhofstad A, Heerschap A (2008) High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies. Magma 21:435\u2013442","journal-title":"Magma"},{"key":"993_CR22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10334-003-0025-5","volume":"16","author":"B Sitter","year":"2004","unstructured":"Sitter B, Bathen TF, Hagen B, Arentz C, Skjeldestad FE, Gribbestad IS (2004) Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. Magma 16:174\u2013181","journal-title":"Magma"},{"key":"993_CR23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/nbm.869","volume":"17","author":"MM Mahon","year":"2004","unstructured":"Mahon MM, deSouza NM, Dina R, Soutter WP, McIndoe GA, Williams AD, Co IJ (2004) Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. NMR Biomed 17:144\u2013153","journal-title":"NMR Biomed"},{"key":"993_CR24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/nbm.1302","volume":"22","author":"SS Silva De","year":"2009","unstructured":"De Silva SS, Payne GS, Thomas V, Carter PG, Ind TEJ, deSouza NM (2009) Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using 1H and 31P magic angle spinning MRS of intact tissue. NMR Biomed 22:191\u2013198","journal-title":"NMR Biomed"},{"key":"993_CR25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1021\/pr8006232","volume":"8","author":"ECY Chan","year":"2009","unstructured":"Chan ECY, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC\/MS). J Proteome Res 8:352\u2013361","journal-title":"J Proteome Res"},{"key":"993_CR26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11306-008-0151-1","volume":"5","author":"M Piotto","year":"2009","unstructured":"Piotto M, Moussallieh F-M, Dillmann B, Imperiale A, Neuville A, Brigand C, Bellocq J-P, Elbayed K, Namer IJ (2009) Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics 5:292\u2013301","journal-title":"Metabolomics"},{"key":"993_CR27","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1021\/pr070063h","volume":"6","author":"Y Yang","year":"2007","unstructured":"Yang Y, Li C, Nie X, Feng X, Chen W, Yue Y, Tang H, Deng F (2007) Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res 6:2605\u20132614","journal-title":"J Proteome Res"},{"key":"993_CR28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1099-1492(200004)13:2<64::AID-NBM612>3.0.CO;2-X","volume":"13","author":"AR Tate","year":"2000","unstructured":"Tate AR, Foxall PJD, Holmes E, Moka D, Spraul M, Nicholson JK, Lindon JC (2000) Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of 1H magic angle spinning (MAS) NMR spectra. NMR Biomed 13:64\u201371","journal-title":"NMR Biomed"},{"key":"993_CR29","first-page":"3195","volume":"27","author":"V Righi","year":"2007","unstructured":"Righi V, Mucci A, Schenetti L, Tosi MR, Grigioni WF, Corti B, Bertaccini A, Franceschelli A, Sanguedolce F, Schiavina R, Martorana G, Tugnoli V (2007) Ex vivo HR-MAS magnetic resonance spectroscopy of normal and malignant human renal tissues. Anticancer Res 27:3195\u20133204","journal-title":"Anticancer Res"},{"key":"993_CR30","first-page":"543","volume":"16","author":"V Tugnoli","year":"2006","unstructured":"Tugnoli V, Mucci A, Schenetti L, Righi V, Calabrese C, Fabbri A, Di Febo G, Tosi MR (2006) Ex vivo HR-MAS magnetic resonance spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa. Oncol Rep 16:543\u2013553","journal-title":"Oncol Rep"},{"key":"993_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lungcan.2009.05.012","volume":"68","author":"KW Jordan","year":"2009","unstructured":"Jordan KW, Adkins CB, Su L, Halpern EF, Mark EJ, Christiani DC, Cheng LL (2009) Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue\u2013serum pairs. Lung Cancer 68:44\u201350","journal-title":"Lung Cancer"},{"key":"993_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/pr9006574","volume":"9","author":"CM Rocha","year":"2010","unstructured":"Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Humpfer E, Spraul M, Carreira IM, Melo JB, Bernardo J, Gomes A, Sousa V, Carvalho L, Duarte IF (2010) Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res 9:319\u2013332","journal-title":"J Proteome Res"},{"key":"993_CR33","volume-title":"World Health Organization Classification of Tumours: tumours of the lung, pleura, thymus and heart","author":"WD Travis","year":"2004","unstructured":"Travis WD, Brambilla E, M\u00fcller-Hermelink HK, Harris C (2004) World Health Organization Classification of Tumours: tumours of the lung, pleura, thymus and heart. IARC Press, Lyon"},{"key":"993_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-7439(00)00122-2","volume":"56","author":"Q-S Xu","year":"2001","unstructured":"Xu Q-S, Liang Y-Z (2001) Monte Carlo cross validation. Chemometr Intell Lab Syst 56:1\u201311","journal-title":"Chemometr Intell Lab Syst"},{"key":"993_CR35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp060067e","volume":"3","author":"K Glunde","year":"2006","unstructured":"Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM (2006) Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm 3:496\u2013506","journal-title":"Mol Pharm"},{"key":"993_CR36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/cbf.1149","volume":"22","author":"GK Balendiran","year":"2004","unstructured":"Balendiran GK, Dabur R, Fraser D (2004) The role of glutathione in cancer. Cell Biochem Funct 22:343\u2013352","journal-title":"Cell Biochem Funct"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-010-0993-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0993-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:35:58Z","timestamp":1559079358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-010-0993-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s00428-010-0993-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]}}}